Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Nov 19;47(1):857.
doi: 10.1007/s10143-024-03119-z.

Comparative efficacy and safety of N-butyl cyanoacrylate vs. Onyx in the treatment of arteriovenous malformations: a systematic review and meta-analysis

Basel Musmar  1 , Joanna M Roy  1 , Hamza Adel Salim  2 , Elias Atallah  1 , Stavropoula I Tjoumakaris  1 , Michael Reid Gooch  1 , Hekmat Zarzour  1 , Ritam Ghosh  1 , Richard F Schmidt  1 , Robert H Rosenwasser  1 , Pascal Jabbour  3
Affiliations
Meta-Analysis

Comparative efficacy and safety of N-butyl cyanoacrylate vs. Onyx in the treatment of arteriovenous malformations: a systematic review and meta-analysis

Basel Musmar et al. Neurosurg Rev. .

Abstract

Since the first use of embolization for cerebral arteriovenous malformations (AVMs) by Luessenhop and Spence in 1960, this procedure has become a cornerstone in the multimodal treatment approach for brain AVMs. Currently, in the United States, the main embolic agents employed are n-butyl cyanoacrylate (NBCA) and Onyx (Medtronic, Minneapolis, MN). This systematic review and meta-analysis aim to compare these two agents in terms of efficacy and safety. An updated guideline for Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was followed. The search strategy involved retrieving articles from PubMed, Scopus, and Web of Science from inception of these databases until June 27th, 2024, using specific search terms. Inclusion criteria were comparative studies of Onyx (Medtronic, Minneapolis, MN) and NBCA, peer-reviewed original studies published in full-text, and studies reporting at least one of the outcomes of interest. Statistical analysis was performed using R software version 4.3.1. After screening 3177 articles, 33 articles were assessed in full-text, and 4 studies were included in the final analysis. These studies included 374 patients, 170 (45.4%) females. There was no significant difference in complication rates between Onyx (Medtronic, Minneapolis, MN) and NBCA (risk ratio [RR]: 0.91; CI: 0.31 to 2.67, p = 0.86) with significant heterogeneity (I²=68%, p = 0.02). Technical success did not differ significantly (RR: 1.38; CI: 0.72 to 2.62, p = 0.33) with significant heterogeneity (I²=73%, p = 0.02). Mortality (RR: 1.5; CI: 0.28 to 8.08, p = 0.64; I²=16%, p = 0.31), morbidity (RR: 1.39; CI: 0.16 to 12.08, p = 0.76; I²=53%, p = 0.14), and blood loss (MD: -0.1; CI: -0.8 to 0.5, p = 0.72; I²=53%, p = 0.15) also showed no significant differences. Both NBCA and Onyx are effective and safe for embolization of cerebral AVMs, with no significant differences in complications, technical success, mortality, morbidity, and blood loss. Further research, particularly randomized controlled trials, is needed to better understand their comparative efficacy and safety.

Keywords: AVM; Meta-analysis; NBCA; Onyx.

PubMed Disclaimer

Conflict of interest statement

Declarations Ethical approval Not Applicable. Informed consent and ethical approval N/A. Competing interests The authors declare no competing interests.

References

    1. Luessenhop AJ, Spence WT (1960) Artificial embolization of cerebral arteries. Report of use in a case of arteriovenous malformation. J Am Med Assoc 172:1153–1155. https://doi.org/10.1001/jama.1960.63020110001009 - DOI - PubMed
    1. Lv X, Zhang Y, Wang J (2020) Systematic review of transcatheter arterial embolization of AVM: indications, bleeding complications, cure rate, and long-term bleeding risk. Neurol India 68(6):1285–1292. https://doi.org/10.4103/0028-3886.304101 - DOI - PubMed
    1. Lv X, Liang S (2020) Update Onyx embolization for plexiform arteriovenous malformation: ante-grade drifting technique. Neuroradiol J 33(5):386–392. https://doi.org/10.1177/1971400920940207 - DOI - PubMed - PMC
    1. Zhang H, Liang S, Lv X (2021) Radio-clinical grading system for transarterial AVM embolization: Tsinghua AVM grading system. Neurosci Inf 1(3):100021. https://doi.org/10.1016/j.neuri.2021.100021 - DOI
    1. Pierot L, Kadziolka K, Litré F, Rousseaux P (2013) Combined treatment of brain AVMs with use of Onyx embolization followed by radiosurgery. AJNR Am J Neuroradiol 34(7):1395–1400. https://doi.org/10.3174/ajnr.A3409 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources